Results
- Showing results for:
- Reset all filters
Search results
-
Journal articleMacLeod MA, Knott KD, Allinson JP, et al., 2025,
Prevalence and Clinical Correlates of Radiologically Detected Coronary Artery Disease in Chronic Obstructive Pulmonary Disease A Cross-Sectional Observational Study
, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol: 211, Pages: 946-956, ISSN: 1073-449X- Cite
- Citations: 3
-
Journal articleChepkirui M, Dellicour S, Musuva R, et al., 2025,
Missed opportunities for digital health data use in healthcare decision-making: A cross-sectional digital health landscape assessment in Homa Bay county, Kenya
, PLOS DIGITAL HEALTH, Vol: 4- Cite
- Citations: 1
-
Journal articleChen J-L, Wang B, Lu Y, et al., 2025,
T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination
, Nature Communications, Vol: 16, ISSN: 2041-1723In 2022, a global mpox outbreak occurred, and remains a concern today. The T cell memory response to MPXV (monkeypox virus) infection has not been fully investigated. In this study, we evaluate this response in convalescent and MVA-BN (Modified Vaccinia Ankara - Bavarian Nordic) vaccinated individuals using VACV-infected cells. Strong CD8+ and CD4+ T cell responses are observed, and T cell responses are biased towards viral early expressed proteins. We identify seven immunodominant HLA-A*02:01 restricted MPXV-specific epitopes and focus our detailed phenotypic and scRNAseq analysis on the immunodominant HLA-A*02:01-G5R18-26-specific CD8+ T cell response. While tetramer+CD8+ T cells share similar differentiation and activation phenotypes, T cells from convalescent individuals show greater cytotoxicity, migratory potential to site of infection and TCR clonal expansion. Our data suggest that effective functional profiles of MPXV-specific memory T cells induced by Mpox infection may have an implication on the long-term protective responses to future infection.
-
Journal articleFeary J, Yu Y, Kabir T, et al., 2025,
Assessment of cancer biomarkers in the Grenfell firefighter cohort study
, SCIENTIFIC REPORTS, Vol: 15, ISSN: 2045-2322 -
Conference paperBegg M, Pyle CJ, Patel N, et al., 2025,
APL-10456; An Adjuvanted Rhinovirus Clinical Vaccine Candidate Which Generates Cross-species Humoral and Th1-polarized Cellular Immunity
, International Conference of the American-Thoracic-Society (ATS), Publisher: AMER THORACIC SOC, ISSN: 1073-449X -
Conference paperLong MB, Hull RC, Gilmour A, et al., 2025,
A Bispecific Monoclonal Antibody Targeting Psl and PcrV for Chronic Pseudomonas Aeruginosa Infection in Patients With Bronchiectasis: Results From a Randomized, Double-Blind Placebo-Controlled Trial (GREAT-2)
, International Conference of the American-Thoracic-Society (ATS), Publisher: AMER THORACIC SOC, ISSN: 1073-449X -
Conference paperWalsh SL, Kanavati F, Montiero M, et al., 2025,
Deep Learning-Based Quantitative CT and CT Phenotype Classification Independently Predict Mortality in Idiopathic Pulmonary Fibrosis, a Prospective Observational Cohort Study
, International Conference of the American-Thoracic-Society (ATS), Publisher: AMER THORACIC SOC, ISSN: 1073-449X -
Conference paperWalsh SL, Sherlock SP, Ostridge K, et al., 2025,
Deep Learning-Based Short-Term Disease Progression Evaluation Supersedes Automated Baseline CT Phenotype in Predicting Outcomes in Idiopathic Pulmonary Fibrosis
, International Conference of the American-Thoracic-Society (ATS), Publisher: AMER THORACIC SOC, ISSN: 1073-449X -
Conference paperJohnson E, Cant EG, Bidgood L, et al., 2025,
Relationships Between Neutrophil Function, Cilia Function, and Microbiome Composition in Bronchiectasis: Interim Results From the Brilliant Study
, 52nd Critical Care Congress of the Society-of-Critical-Care-Medicine (SCCM), Publisher: AMER THORACIC SOC, ISSN: 1073-449X -
Conference paperCraster A, Bussell E, Sherlock SP, et al., 2025,
Deep Learning-based Quantitative CT and Proteomics for Predicting Outcomes in Idiopathic Pulmonary Fibrosis
, International Conference of the American-Thoracic-Society (ATS), Publisher: AMER THORACIC SOC, ISSN: 1073-449X -
Conference paperDiop A, Hughes R, Muellerova H, et al., 2025,
Differences in the Characteristics and Outcomes by Sex in Patients With Physician-diagnosed Asthma and/or COPD in the NOVELTY Study
, International Conference of the American-Thoracic-Society (ATS), Publisher: AMER THORACIC SOC, ISSN: 1073-449X -
Journal articleBaraldi F, Mah J, Braddy-Green A, et al., 2025,
The relationship between eosinophilic activation and mucus plug formation in COPD
, American Journal of Respiratory and Critical Care Medicine, Vol: 211, ISSN: 1073-449X -
Journal articleBartlett-Pestell S, Wong T, Wedzicha JA, 2025,
Exacerbating the Problem: Chronic Obstructive Pulmonary Disease and Atrial Fibrillation
, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol: 211, Pages: 695-697, ISSN: 1073-449X- Cite
- Citations: 1
-
Journal articleFinney LJ, Mah J, Duvall M, et al., 2025,
Select Airway Specialized Proresolving Mediators Are Associated with Recovery from Nonviral Chronic Obstructive Pulmonary Disease Exacerbations
, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol: 211, Pages: 803-813, ISSN: 1073-449X- Cite
- Citations: 1
-
Journal articleBaraldi F, Bartlett-Pestle S, Allinson JP, et al., 2025,
Blood eosinophil count stability in COPD and the eosinophilic exacerbator phenotype
, American Journal of Respiratory and Critical Care Medicine, Vol: 211, Pages: 870-872, ISSN: 1073-449X -
Journal articleMeghji J, Auld S, Bisson G, et al., 2025,
Post-tuberculosis lung disease: towards prevention, diagnosis and care
, The Lancet Respiratory Medicine, Vol: 13, Pages: 460-472, ISSN: 2213-2600There is a growing body of data describing the high burden of respiratory sequelae seen among tuberculosis survivors, including children, adolescents, and adults. This group of sequelae are known as post-tuberculosis lung disease and include parenchymal damage, airway disease, and pulmonary vascular disease. It is thought that approximately half of pulmonary tuberculosis survivors have ongoing structural pathology, lung function impairment, or respiratory symptoms after the resolution of active disease. Post-tuberculosis lung disease has been associated with adverse patient outcomes, including persistent symptoms and functional impairment, ongoing health seeking, and impacts on income and employment. There is still much to understand about the epidemiology and nature of post-tuberculosis lung disease, but in this Review we focus on strategies for prevention, diagnosis, and care to inform the ongoing work of tuberculosis-affected communities, health-care providers, researchers, and policy makers. We summarise recent data, highlight evidence gaps, and suggest key research priorities for those working in the field.
-
Conference paperOzoh OB, Mohammed J, Kayembe-Kitenge T, et al., 2025,
Asthma Among African Adolescents: Findings From the Chronic Respiratory Disease Observatory for Africa (CHEST-Africa)
, International Conference of the American-Thoracic-Society (ATS), Publisher: AMER THORACIC SOC, ISSN: 1073-449X -
Conference paperHughes R, McKellar D, Arad N, et al., 2025,
Coving Index: A Novel, Sensitive Spirometric Marker of Small Airways Obstruction10.1164/ajrccm.2025.211.Abstracts.A2566
, International Conference of the American-Thoracic-Society (ATS), Publisher: AMER THORACIC SOC, ISSN: 1073-449X -
Conference paperTiddens H, Makani P, Bonte M, et al., 2025,
Changes in Low Attenuation Regions and Arterial and Venous Blood Volume Distribution in Response to CFTR Modulator Therapy in People With Cystic Fibrosis
, International Conference of the American-Thoracic-Society (ATS), Publisher: AMER THORACIC SOC, ISSN: 1073-449X -
Journal articleHowlett P, Szram J, Feary J, 2025,
Occupational lung disease: what the general physician needs to know
, Clinical Medicine, Vol: 25, ISSN: 1470-2118Occupational exposures are a common and preventable cause of lung disease. About one in six cases of chronic obstructive pulmonary disease (COPD) and asthma worldwide are related to work.Early recognition of occupational lung disease improves outcomes. Doctors should ask about work history in patients with respiratory symptoms. This educational review article briefly outlines key clinical features, relevant to the general physician, of common occupational lung diseases seen in the UK. These conditions include work-related asthma, pneumoconioses, hypersensitivity pneumonitis and COPD.Referral to a specialist is recommended when an occupational cause is suspected. Most occupational lung diseases are preventable with adequate workplace safety measures and early medical attention.
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.